{"text": "Studies have shown that weight can impact the pharmacodynamics of\n\nantipsychotics, leading to changes in drug efficacy. For instance, a study on\n\nolanzapine found that obese patients had higher plasma concentrations\n\ncompared to non-obese patients (Kaplan et al., 2017). This may be attributed\n\nto the increased volume of distribution in obese individuals.\n\nMechanisms Underlying Weight-Related Changes\n\nSeveral mechanisms have been proposed to explain the weight-related", "embedding": []}